BD reports expiry of 3.000% notes due 2026.
M2 EQUITYBITES-March 2, 2018-BD reports expiry of 3.000% notes due 2026
(C)2018 M2 COMMUNICATIONS http://www.m2.com
Medical company BD (Becton, Dickinson and Company) (NYSE:BDX) disclosed on Thursday the expiry of its 3.000% notes due 15 May 2026 at 17:00, New York City time, on 1 March 2018 (the expiration date).
As of the expiration date, a total of USD460m aggregate principal amount of notes were validly tendered and not validly withdrawn, representing approximately 98.04% of the total outstanding aggregate principal amount of notes, stated the company.
The company had offered to repurchase any and all of its outstanding 3.000% notes due 15 May 2026 under the terms and conditions in the offer dated 8 January 2018.
In conjunction, the holders who validly tendered and did not validly withdraw their notes prior to the expiration date are entitled to receive cash equal to 101% of the principal amount thereof plus accrued and unpaid interest, if any, to the date of purchase, subject to the rights of holders of notes on the relevant record date to receive interest due on the relevant interest payment date, which is equivalent to USD1,015.58 per USD1,000 principal amount of notes tendered.
According to the company, the offer is expected to settle on 6 March 2018. The tender and information agentris Global Bondholder Services Corporation.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||Mar 2, 2018|
|Previous Article:||Digital Realty announces common and preferred stock dividends for Q1 2018.|
|Next Article:||NexPoint Credit Strategies Fund declares regular dividend of USD0.20 per share for March 2018.|